 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
 |
|
|
|
|
 |
||||||||
|
|
 |
|
 |
 |
 |
 |
01.17.07 - CEO William Heiden comments on press release and progress on ghrelin antagonist compound in interview on New England Cable Network (sound).
Mouse over the image for video controls. [ back to top ] |
|||
 |
||||
 |
 |
 |
 |
|
|
|
|
|
|
|
|
|
|
||||||
 |
|
|
 |
||||||
|
|
12 Emily Street, Cambridge, MA 02139 Ph: 617-995-7000 Fx: 617-995-7050 E-mail: info@elixirpharm.com |
|
||||||
 |
|
|
 |
||||||
| © 2008 Elixir Pharmaceuticals, Inc. |
